JPS6411005B2 - - Google Patents
Info
- Publication number
- JPS6411005B2 JPS6411005B2 JP56153034A JP15303481A JPS6411005B2 JP S6411005 B2 JPS6411005 B2 JP S6411005B2 JP 56153034 A JP56153034 A JP 56153034A JP 15303481 A JP15303481 A JP 15303481A JP S6411005 B2 JPS6411005 B2 JP S6411005B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- general formula
- solvent
- extract
- hexane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 β-D-glucopyranosyl Chemical group 0.000 claims description 4
- 239000002220 antihypertensive agent Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 150000004777 chromones Chemical class 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 230000004531 blood pressure lowering effect Effects 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000000203 mixture Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000208173 Apiaceae Species 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 102000006995 beta-Glucosidase Human genes 0.000 description 2
- 108010047754 beta-Glucosidase Proteins 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000002021 butanolic extract Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- 239000002035 hexane extract Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000401 methanolic extract Substances 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000092897 Angelica japonica Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000229182 Ledebouriella seseloides Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 239000009520 bofu-tsusho-san Substances 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012059 conventional drug carrier Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000011597 hartley guinea pig Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008063 pharmaceutical solvent Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56153034A JPS5855420A (ja) | 1981-09-29 | 1981-09-29 | 血圧降下剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56153034A JPS5855420A (ja) | 1981-09-29 | 1981-09-29 | 血圧降下剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5855420A JPS5855420A (ja) | 1983-04-01 |
| JPS6411005B2 true JPS6411005B2 (ko) | 1989-02-23 |
Family
ID=15553518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56153034A Granted JPS5855420A (ja) | 1981-09-29 | 1981-09-29 | 血圧降下剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5855420A (ko) |
-
1981
- 1981-09-29 JP JP56153034A patent/JPS5855420A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5855420A (ja) | 1983-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH04243822A (ja) | カルシウム拮抗剤 | |
| WO2004039759A1 (fr) | Compose naturel servant dans le traitement de diabetes, sa preparation et son utilisation | |
| JP3128823B2 (ja) | 制癌化合物およびその製造法 | |
| JPS6411005B2 (ko) | ||
| EP1411909B1 (en) | Pharmaceutical composition comprising (-)-secoisolariciresinol | |
| JPH0952899A (ja) | ロイコトリエン拮抗剤 | |
| JPH0840912A (ja) | 糖吸収抑制剤 | |
| JPH07267864A (ja) | 体温降下剤 | |
| EP1411919B1 (en) | (-)-olivil as antioxidant | |
| US6562381B2 (en) | (+)-Cycloolivil as antioxidant obtained from natural source namely stereospermum personatum | |
| JPS6033086B2 (ja) | 解熱剤 | |
| JPH024790A (ja) | 抗潰瘍剤 | |
| JPH0285211A (ja) | 新規フェネチルアルコール配糖体および免疫抑制剤 | |
| JPS607971B2 (ja) | 制癌剤 | |
| JPS62207213A (ja) | 抗癌剤 | |
| JPS5855419A (ja) | 血圧降下剤 | |
| JPH0240394A (ja) | ５‐リポキシゲナーゼ阻害剤 | |
| KR930004935B1 (ko) | 항궤양 및 위산분비억제 효과를 가지는 약학적제제 | |
| JPS607967B2 (ja) | 利胆剤 | |
| Rao et al. | Olivil as antioxidant which is obtained from a new natural source namely Stereospermum personatum | |
| JPS6210232B2 (ko) | ||
| JPH04208222A (ja) | 抗炎症および抗アレルギー剤 | |
| JPH0369327B2 (ko) | ||
| JPH0228596B2 (ko) | ||
| JPS6052731B2 (ja) | 利胆剤 |